Rafail A. Kotronias MBChB, MSc , Jason L. Walsh MBChB , Stefano Andreaggi MD , Leonardo Portolan MD , Alessandro Maino MD , Federico Marin MD , Jason Chai MBBCh , Ikboljon Sobirov MSc , Muhammad Sheikh MD , Thomas J. Cahill MBBS, DPhil , Andrew J. Lucking MBChB, PhD , Max Costello BSc , Eva Fraile Moreno MScNurs , Vrinda Haridas BNurs , Anisha Shaji BNurs , Hector M. Garcia-Garcia MD, PhD , Keith M. Channon MBChB, MD , Adrian P. Banning MBChB, MD , Jeremy P. Langrish MBBCh, PhD , Giovanni Luigi De Maria MD, PhD
{"title":"Stent-Retriever Thrombectomy in STEMI With Large Thrombus Burden","authors":"Rafail A. Kotronias MBChB, MSc , Jason L. Walsh MBChB , Stefano Andreaggi MD , Leonardo Portolan MD , Alessandro Maino MD , Federico Marin MD , Jason Chai MBBCh , Ikboljon Sobirov MSc , Muhammad Sheikh MD , Thomas J. Cahill MBBS, DPhil , Andrew J. Lucking MBChB, PhD , Max Costello BSc , Eva Fraile Moreno MScNurs , Vrinda Haridas BNurs , Anisha Shaji BNurs , Hector M. Garcia-Garcia MD, PhD , Keith M. Channon MBChB, MD , Adrian P. Banning MBChB, MD , Jeremy P. Langrish MBBCh, PhD , Giovanni Luigi De Maria MD, PhD","doi":"10.1016/j.jacadv.2025.101893","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Percutaneous coronary intervention (PCI) restores epicardial flow in ST-segment elevation myocardial infarction (STEMI), but large thrombus burden (LTB) can impair myocardial perfusion due to embolization. While manual aspiration (MA) devices have limited efficacy in STEMI, the success of stent-retriever thrombectomy (SRT) in stroke suggests it as a promising option for STEMI.</div></div><div><h3>Objectives</h3><div>The RETRIEVE AMI (stent-retriever thrombectomy for thrombus burden reduction in patients with acute myocardial infarction) trial assessed the safety and efficacy of Solitaire X SRT vs Export MA in STEMI patients with LTB.</div></div><div><h3>Methods</h3><div>This single-center study enrolled 81 STEMI patients with LTB (TIMI thrombus grade ≥4) and randomized them to PCI, MA-assisted, or SRT-assisted PCI. The primary endpoint was difference in prestent thrombus volume by optical coherence tomography between SRT and either comparator; coprimary endpoints included device-related target vessel complications and major adverse cardiac and cerebrovascular events through 6 months.</div></div><div><h3>Results</h3><div>SRT was performed in 26 cases (one crossover), and MA in 27. No device-related arterial complications or cerebrovascular events occurred in the SRT arm. Baseline thrombus volume was significantly higher in the SRT group (18.3 mm<sup>3</sup>) compared to MA (7.7 mm<sup>3</sup>) and no modification (9.8 mm<sup>3</sup>; <em>P</em> = 0.04). Prestent thrombus volume was not significantly different between SRT (7.7; IQR: 2.3-18.6) and either MA (4.8; IQR: 1.8-8.4; <em>P</em> = 0.17) or no thrombus modification (9.8; IQR: 4.5-18.1; <em>P</em> = 1.00). Both techniques significantly reduced prestent thrombus burden (SRT: 12.8%; IQR: 4.4%-21.5%; <em>P</em> = 0.016 and MA: 13.0%; IQR: 3.8%-19.4%; <em>P</em> = 0.003) compared to no modification (22.8%; IQR: 10.4%-27.7%). No device-related clinically relevant arterial injury was detected and in-hospital and 6-month major adverse cardiac and cerebrovascular events did not differ between arms.</div></div><div><h3>Conclusions</h3><div>RETRIEVE AMI demonstrates the feasibility of Solitaire X SRT in STEMI with LTB. Prestent thrombus volume was not different between SRT, MA, or no thrombus modification, although SRT extracted larger thrombus volume than MA. Larger multicenter studies using optical coherence tomography-based criteria are needed to minimize variability and enhance comparative assessments.</div></div>","PeriodicalId":73527,"journal":{"name":"JACC advances","volume":"4 7","pages":"Article 101893"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC advances","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772963X25003138","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Percutaneous coronary intervention (PCI) restores epicardial flow in ST-segment elevation myocardial infarction (STEMI), but large thrombus burden (LTB) can impair myocardial perfusion due to embolization. While manual aspiration (MA) devices have limited efficacy in STEMI, the success of stent-retriever thrombectomy (SRT) in stroke suggests it as a promising option for STEMI.
Objectives
The RETRIEVE AMI (stent-retriever thrombectomy for thrombus burden reduction in patients with acute myocardial infarction) trial assessed the safety and efficacy of Solitaire X SRT vs Export MA in STEMI patients with LTB.
Methods
This single-center study enrolled 81 STEMI patients with LTB (TIMI thrombus grade ≥4) and randomized them to PCI, MA-assisted, or SRT-assisted PCI. The primary endpoint was difference in prestent thrombus volume by optical coherence tomography between SRT and either comparator; coprimary endpoints included device-related target vessel complications and major adverse cardiac and cerebrovascular events through 6 months.
Results
SRT was performed in 26 cases (one crossover), and MA in 27. No device-related arterial complications or cerebrovascular events occurred in the SRT arm. Baseline thrombus volume was significantly higher in the SRT group (18.3 mm3) compared to MA (7.7 mm3) and no modification (9.8 mm3; P = 0.04). Prestent thrombus volume was not significantly different between SRT (7.7; IQR: 2.3-18.6) and either MA (4.8; IQR: 1.8-8.4; P = 0.17) or no thrombus modification (9.8; IQR: 4.5-18.1; P = 1.00). Both techniques significantly reduced prestent thrombus burden (SRT: 12.8%; IQR: 4.4%-21.5%; P = 0.016 and MA: 13.0%; IQR: 3.8%-19.4%; P = 0.003) compared to no modification (22.8%; IQR: 10.4%-27.7%). No device-related clinically relevant arterial injury was detected and in-hospital and 6-month major adverse cardiac and cerebrovascular events did not differ between arms.
Conclusions
RETRIEVE AMI demonstrates the feasibility of Solitaire X SRT in STEMI with LTB. Prestent thrombus volume was not different between SRT, MA, or no thrombus modification, although SRT extracted larger thrombus volume than MA. Larger multicenter studies using optical coherence tomography-based criteria are needed to minimize variability and enhance comparative assessments.